Direkt zum Inhalt
Merck

Potent benzimidazolone based human beta(3)-adrenergic receptor agonists.

Bioorganic & medicinal chemistry letters (2006-08-26)
Don R Finley, Michael G Bell, Anthony G Borel, William E Bloomquist, Marlene L Cohen, Mark L Heiman, Aidas Kriauciunas, Donald P Matthews, Tania Miles, David A Neel, Christopher J Rito, Daniel J Sall, Anthony J Shuker, Thomas W Stephens, Frank C Tinsley, Mark A Winter, Cynthia D Jesudason
ZUSAMMENFASSUNG

The synthesis and biological evaluation of a series of benzimidazolone beta(3) adrenergic receptor agonists are described. A trend toward the reduction of rat atrial tachycardia upon increasing steric bulk at the 3-position of the benzimidazolone moiety was observed.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
4-(2-Keto-1-benzimidazolinyl)piperidin, 98%